Huntleigh Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$189K Sell
11,907
-1,899
-14% -$29.4K 0.03% 293
2026
Q1
$187K Sell
13,806
-4
-0% -$56 0.03% 271
2025
Q4
$172K Sell
13,810
-10
-0.1% -$108 0.03% 256
2025
Q3
$137K Sell
13,820
-674
-5% -$6.56K 0.02% 269
2025
Q2
$129K Buy
14,494
+648
+5% +$5.48K 0.03% 263
2025
Q1
$121K Sell
13,846
-14
-0.1% -$147 0.03% 250
2024
Q4
$173K Buy
+13,860
New +$170K 0.04% 250

Other funds holding VTRS

Huntleigh Advisors's VTRS Position: Q2 2026 in Review

Huntleigh Advisors reduced its Viatris (VTRS) stake by 14% in Q2 2026, selling an estimated $29.4K and leaving 11,907 shares worth $189K. The position accounts for 0.03% of the portfolio, ranked #293.

Huntleigh Advisors first reported a position in VTRS in Q4 2024 and has held it in 7 quarters since. 1,024 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Huntleigh Advisors held 11,907 shares of Viatris worth $189K as of Q2 2026.
  • Huntleigh Advisors sold 1,899 Viatris shares in Q2 2026, an estimated $29.4K.
  • Viatris made up 0.03% of Huntleigh Advisors's portfolio in Q2 2026, its #293 holding.
  • Huntleigh Advisors first reported a position in Viatris in Q4 2024 and has held it in 7 quarters since.
  • 1,024 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Huntleigh Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.